Regional distribution of psoriasis in Italy
- PMID: 18269600
- DOI: 10.1111/j.1468-3083.2007.02423.x
Regional distribution of psoriasis in Italy
Abstract
Background: Psoriasis is a chronic disease affecting skin and joints; the prevalence varies considerably within ethnic groups and countries.
Objective: The aim of this study was to examine the prevalence of psoriasis across Italy and to identify regional differences.
Methods: The study was conducted in February 2006. A questionnaire was created to survey the prevalence and the geographical distribution of psoriasis in Italy. A representative sample of 3500 families from the contiguous 20 Italian regions was interviewed by a telematic panel.
Results: A total of 4109 individuals were interviewed. The research showed that 2.9% of Italians declared suffering from psoriasis (regional range: 0.8-4.5%); that 52% knew somebody with psoriasis; that 33% knew well the meaning of psoriasis; and that 31% of individuals affected from psoriasis defined the effect on quality of life as high.
Conclusion: In association with the socio-cultural data, this is the first study describing the variation in prevalence of psoriasis among Italian regions.
Similar articles
-
A clinical survey of psoriasis in Italy: 1st AISP report. Interdisciplinary Association for the Study of Psoriasis.J Eur Acad Dermatol Venereol. 1998 Mar;10(2):125-9. J Eur Acad Dermatol Venereol. 1998. PMID: 9553908
-
The reduced Impact of Psoriasis Questionnaire has good psychometric properties in Italian patients.Dermatology. 2007;215(4):348-51. doi: 10.1159/000107629. Dermatology. 2007. PMID: 17911994
-
Prevalence of psoriasis in China: a population-based study in six cities.Eur J Dermatol. 2012 Sep-Oct;22(5):663-7. doi: 10.1684/ejd.2012.1802. Eur J Dermatol. 2012. PMID: 22910173
-
Epidemiology in psoriasis research.Hawaii Med J. 1982 Nov;41(11):430-42. Hawaii Med J. 1982. PMID: 6761311 Review. No abstract available.
-
Psoriasis: epidemiology, clinical features, and quality of life.Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii18-23; discussion ii24-5. doi: 10.1136/ard.2004.033217. Ann Rheum Dis. 2005. PMID: 15708928 Free PMC article. Review.
Cited by
-
Biological therapy utilization, switching, and cost among patients with psoriasis: retrospective analysis of administrative databases in Southern Italy.Clinicoecon Outcomes Res. 2017 Dec 1;9:741-748. doi: 10.2147/CEOR.S147558. eCollection 2017. Clinicoecon Outcomes Res. 2017. PMID: 29238210 Free PMC article.
-
Depression and the risk of psoriasis in US women.J Eur Acad Dermatol Venereol. 2013 Sep;27(9):1163-7. doi: 10.1111/j.1468-3083.2012.04703.x. Epub 2012 Oct 3. J Eur Acad Dermatol Venereol. 2013. PMID: 23030685 Free PMC article.
-
Budget impact model of secukinumab for the treatment of moderate-to-severe psoriasis, psoriatic arthritis, and ankylosing spondylitis in Italy: a cross-indication initiative.Clinicoecon Outcomes Res. 2018 Aug 30;10:477-491. doi: 10.2147/CEOR.S171560. eCollection 2018. Clinicoecon Outcomes Res. 2018. PMID: 30214261 Free PMC article.
-
Epidemiology of Psoriasis and Psoriatic Arthritis in Italy-a Systematic Review.Curr Rheumatol Rep. 2018 May 30;20(7):43. doi: 10.1007/s11926-018-0753-1. Curr Rheumatol Rep. 2018. PMID: 29846817
-
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy.Pharmacoecon Open. 2023 May;7(3):405-416. doi: 10.1007/s41669-023-00404-3. Epub 2023 Mar 16. Pharmacoecon Open. 2023. PMID: 36929647 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical